Clera home
·Dashboard

Jobs at Latigo Biotherapeutics, Inc. (Now Hiring) — 2 open

Latigo Biotherapeutics, Inc. logoLatigo Biotherapeutics, Inc.

Associate Director, Clinical Pharmacology

San Francisco, California, United States · Hybrid

$205k–$235k/yr

Senior+$300M raised

Title: Associate Director, Clinical Pharmacology Location: Thousand Oaks, CA or San Francisco, CA Company Description: Latigo Biotherapeutics, Inc. is a private, early-stage biotechnology company focused on discovering a…

Skills: Clinical Pharmacology, Small Molecule Development, Phase 1 Study Design, PK Analysis, Phoenix WinNonLin

Latigo Biotherapeutics, Inc. logoLatigo Biotherapeutics, Inc.

Associate Director, Toxicology

San Francisco, California, United States · Hybrid

$200k–$230k/yr

Senior+$300M raised

We are seeking a highly motivated and experienced Associate Director of Toxicology (Nonclinical Safety) to support the advancement of our pipeline programs. This individual will play a key role in designing, executing, a…

Skills: Nonclinical Safety Strategy, Toxicology Study Design, CRO Management, Regulatory Document Authoring, GLP Compliance

Latigo Biotherapeutics, Inc. logo

Associate Director, Clinical Pharmacology

Latigo Biotherapeutics, Inc.

San Francisco, California, United States • Hybrid

Apply
Senior+

Tired of cold applications?

Sign up with Clera and we'll reach out the moment a role actually fits you — no more spraying applications into the void.

  • $205k–$235k/yr
  • Full-time
  • postgraduate degree
  • Posted 19d ago
  • ~40 hrs/week

Responsibilities

The Associate Director will lead the clinical pharmacology strategy and oversight for multiple clinical and Pre-IND programs from first-in-human to registration. This includes designing studies, authoring regulatory documents, and managing external consultants and vendors.

Requirements

Candidates should possess a PharmD or PhD with over 8 years of experience in clinical pharmacology supporting early development of small molecules. Proficiency in Phoenix WinNonLin and experience with Phase 1 studies and regulatory submissions are highly preferred.

Full job description

Title: Associate Director, Clinical Pharmacology

Location: Thousand Oaks, CA or San Francisco, CA

Company Description:

Latigo Biotherapeutics, Inc. is a private, early-stage biotechnology company focused on discovering and developing the next generation of non-opioid medicines for pain and pain-related syndromes. Our mission is the development of novel therapies that transform the lives of patients. We have a robust pipeline with programs ranging from preclinical to late phase. The company, whose headquarters is in Thousand Oaks, CA, with a satellite office in San Francisco, CA, has a highly successful management team as well as an experienced Board of Directors. At Latigo, we value honest science, patient-focus, and innovation.

Position Description:

Reporting to the Head of Clinical Pharmacology, the Associate Director, Clinical Pharmacology will work in our clinical development teams, with significant responsibility for the Clinical Pharmacology package of multiple clinical and Pre-IND programs. In this role, you will help formulate clinical pharmacology strategies from the FIH through registration.

Primary Responsibilities:

  • As part of the development team, you will provide expertise in the clinical development of small molecule programs, in particular the design and oversight for clinical pharmacology studies.
  • Lead and manage design and conduct of clinical pharmacology studies of increasing complexity.
  • Analyze, interpret and author documents for clinical submissions, including but not limited to clinical study protocols and reports, Investigator’s Brochures, and the clinical pharmacology sections of regulatory submissions.
  • Interact with regulatory agencies (US and ex-US) as needed.
  • You will be accountable for study-to-program level clinical pharmacology aspects of compounds in the discovery to development stage.
  • You will be responsible for oversight and interaction with consultants and vendors assigned to support clinical pharmacology tasks including PK, PKPD, and clinical assay development.

Qualifications and Requirements:

  • PharmD or PhD in a relevant discipline preferred.
  • 8+ years of experience in Clinical Pharmacology supporting early development in a biotech or pharmaceutical organization.
  • Prior, robust clinical pharmacology experience with small molecules is required. Experience in the design and conduct of multiple types of Phase 1 studies (e.g. FIH, DDI, FE, rBA, etc.) preferred.
  • Proficiency with modern PK analysis software (e.g. Phoenix WinNonLin) required.
  • Knowledge of regulatory requirements for clinical pharmacology preferred.
  • Strong interpersonal skills, and ability to influence development program teams.
  • Excellent verbal and written communication skills, and ability to clearly convey complex concepts to technical and non-technical audiences preferred.
  • Ability to work independently in a dynamic and fast-paced environment.
  • Experience in therapeutic areas related to pain management preferred.
  • Experience with regulatory submissions in early and late development is preferred.

Related keywords

Clinical PharmacologySmall MoleculesFIHDDIFErBAPhoenix WinNonLinPKPKPDInvestigator's BrochuresPre-INDBiotechnologyPain ManagementRegulatory AffairsClinical DevelopmentClinical Assay Development

About Latigo Biotherapeutics, Inc.

LinkedInVisit site

Uniquely poised to disrupt pain therapy.

Industry
Biotechnology Research
Company size
11-50 employees
Headquarters
Thousand Oaks, CA
LinkedIn followers
9,124
Total funding
$300M

Latigo Biotherapeutics is a private clinical-stage biopharmaceutical company committed to developing innovative non-opioid pain medicines designed to stop the transmission of pain without the risk of addiction, with the goal to provide effective, rapid-acting pain relief. Latigo is supported by leading investors, including Westlake Village BioPartners, Foresite Capital, 5AM Ventures, and Blue Owl Capital. Latigo’s lead program is LTG-001, an oral, selective Nav1.8 inhibitor in development to treat acute pain.

Offices: Thousand Oaks, CA, US

Health CareBiotechnologyMedicalTherapeutics
View all jobs at Latigo Biotherapeutics, Inc.

About Latigo Biotherapeutics, Inc.

LinkedInVisit site

Uniquely poised to disrupt pain therapy.

Industry
Biotechnology Research
Company size
11-50 employees
Headquarters
Thousand Oaks, CA
LinkedIn followers
9,124
Total funding
$300M

Latigo Biotherapeutics is a private clinical-stage biopharmaceutical company committed to developing innovative non-opioid pain medicines designed to stop the transmission of pain without the risk of addiction, with the goal to provide effective, rapid-acting pain relief. Latigo is supported by leading investors, including Westlake Village BioPartners, Foresite Capital, 5AM Ventures, and Blue Owl Capital. Latigo’s lead program is LTG-001, an oral, selective Nav1.8 inhibitor in development to treat acute pain.

Offices: Thousand Oaks, CA, US

Health CareBiotechnologyMedicalTherapeutics
View all jobs at Latigo Biotherapeutics, Inc.

Similar companies hiring

Thermo Fisher Scientific (2347)Roche (1165)CSL (987)Amgen (870)ICON plc (736)Syneos Health (400)Mineralys Therapeutics, Inc. (314)Fortrea (252)Agilent Technologies (247)Gilead Sciences (204)BeiGene (174)Genentech (172)
Clera home

Your AI-talent agent. Connecting talents with dream jobs.

Earn $5,000

Tools

  • Salary Calculator
  • Resume Review
  • Startup Map

Explore

  • Jobs
  • Discover Jobs
  • Companies
  • Referral

Platform

  • Pricing
  • Integrations
  • Partners
  • Acquihire

Clera

  • Manifesto
  • Engineering
  • We are hiring!
  • FAQs
  • Blog
  • Press

Tools

  • Salary Calculator
  • Resume Review
  • Startup Map

Explore

  • Jobs
  • Discover Jobs
  • Companies
  • Referral

Platform

  • Pricing
  • Integrations
  • Partners
  • Acquihire

Clera

  • Manifesto
  • Engineering
  • We are hiring!
  • FAQs
  • Blog
  • Press

© 2026 Clera Labs, Inc.

PrivacyTermsBug Bounty